Etofenamate
Meda Pharma GmbH & Co. KG
1499 Items
2019-09-19
- done All payments are SSL encrypted
- done Full Refund if you haven't received your order
- done International shipping to the USA, UK and Europe
Clinical Pharmacology
NSAIDs for external use. It has a local anti-inflammatory and analgesic effect.
Indications
Articular syndrome, including:
- rheumatic genesis;
- myalgia;
- myositis;
- lumbago;
- ischalgia;
- bursitis;
- tendovaginitis;
- stretching;
- sprains;
- bruises and contusions without compromising tissue integrity.
Composition
1 g of gel contains:
Active substance: Etofenamat 50 mg.
Excipients: cetomacrogol oleate - 60 mg, isopropanol - 381 mg, macrogol 400 - 30 mg, carbomer 940 - 10.3 mg, sodium hydroxide - 0.75 mg, water - 465.25 mg.
No customer reviews for the moment.
Dosage and Administration
The drug is used one or several times a day by spraying from a distance of 10-20 cm so that the entire affected surface is covered with the drug (foam).
The duration of the course of therapy depends on the severity of the disease.
Adverse reactions
Very rarely: redness, rash, burning, itching in the area of application.
Contraindications
- Hypersensitivity to etofenamato and other derivatives of anthranilic and flufenamic acids and other NSAIDs;
- damaged and / or eczema affected skin;
- pregnancy;
- lactation period;
- childhood.
Drug interactions
Drug interaction of the drug is not described.
Pregnancy and Lactation
Contraindicated in pregnancy and lactation.
Special instructions
Avoid contact with the damaged and eczema affected skin.
If an excess amount of the drug is accidentally applied to the skin, it should be immediately washed off.
Nursing mothers for the period of treatment should refuse breastfeeding.
Use in Pediatrics
The drug is contraindicated for use in children.
Overdosage
Currently, no cases of overdose have been reported.
- Brand name: Revmonn
- Active ingredient: Etofenamat
- Dosage form: Gel for external use.
- Manufacturer: Meda Pharma GmbH & Co. KG
- Country of Origin: Switzerland
Studies and clinical trials of Etofenamate (Click to expand)
- Safety and bleeding profile of continuous levonorgestrel 90 mcg/ethinyl estradiol 20 mcg based on 2 years of clinical trial data in Canada
- Contact dermatitis from an antirheumatic gel containing etofenamate
- Contact urticaria to etofenamate
- Allergic dermatitis from etofenamate
- Extoliative dermatitis with etofenamate
- Contact dermatitis due to etofenamate
- Contact dermatitis from etofenamate
- Allergic contact dermatitis from etofenamate: report of 9 cases
- Photoallergic contact dermatitis due to flufenamic acid and etofenamate
- Allergic contact dermatitis to etofenamate. Cross-reaction to other nonsteroidal anti-inflammatory drugs
- Allergic and photoallergic contact dermartitis from etofenamate: study of 14 cases
- Action spectrum for etofenamate photoallergic contact dermatitis
- The isolated perfused bovine udder as an in vitro model of percutaneous drug absorption skin viability and percutaneous absorption of dexamethasone, benzoyl peroxide, and etofenamate
- Analgesic effect of indometacin, etofenamate and of ibuprofen applied locally in animals and man
- Intramuscular Etofenamate versus Diclofenac in the Relief of Renal Colic
- A Double-Blind Study of the Efficacy of Topical Ketorolac Tromethamine Gel in the Treatment of Ankle Sprain, in Comparison to Placebo and Etofenamate
- Combined contact and photocontact allergic dermatitis to etofenamate in flogoprofen gel
- Comparative Study of Etofenamate and Fentanyl for Outpatient Extracorporeal Shockwave Lithotripsy
- Etofenamate/flufenamic acid
- Etofenamate
- Etofenamate
- Etofenamate
- Etofenamate
- Etofenamate
8 other products in the same category:
arrow_upward